Hennion & Walsh Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $499K | Buy |
+15,005
| New | +$499K | 0.02% | 672 |
|
|
2023
Q2 | – | Sell |
-22,525
| Closed | -$517K | – | 798 |
|
|
2023
Q1 | $517K | Sell |
22,525
-772
| -3% | -$17.7K | 0.03% | 498 |
|
|
2022
Q4 | $654K | Buy |
23,297
+2,944
| +14% | +$82.6K | 0.04% | 436 |
|
|
2022
Q3 | $576K | Sell |
20,353
-282
| -1% | -$7.98K | 0.04% | 453 |
|
|
2022
Q2 | $457K | Sell |
20,635
-307
| -1% | -$6.8K | 0.03% | 508 |
|
|
2022
Q1 | $610K | Buy |
20,942
+427
| +2% | +$12.4K | 0.03% | 471 |
|
|
2021
Q4 | $674K | Buy |
20,515
+1,283
| +7% | +$42.2K | 0.03% | 464 |
|
|
2021
Q3 | $888K | Buy |
19,232
+6,586
| +52% | +$304K | 0.05% | 375 |
|
|
2021
Q2 | $697K | Sell |
12,646
-2,735
| -18% | -$151K | 0.04% | 444 |
|
|
2021
Q1 | $794K | Buy |
+15,381
| New | +$794K | 0.05% | 410 |
|